Thrombosis in Patients With Multiple Myeloma in an University Medical Center
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Multiple Myeloma
Related studies linked through entity extraction aliases.
Using Mass Spectrometry (EasyM) Detecting Minimal Residual Disease (MRD) in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- N/A
Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies
- Status
- RECRUITING
- Phase
- NA
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Telo Genomics Technology to Detect & Profile Multiple Myeloma MRD
- Status
- RECRUITING
- Phase
- N/A
Iberdomide-dexamethasone Alone or in Combination With Standard MM Treatment Regimens in Transplant Ineligible Newly Diagnosed Patients.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
High-dose Chemotherapy+G-CSF in Peripheral Blood Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy of Anti-BCMA/GPRC5D CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma(rr/MM)
- Status
- UNKNOWN
- Phase
- PHASE2
Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT
- Status
- RECRUITING
- Phase
- PHASE2
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Immuno-PRISM (PRecision Intervention Smoldering Myeloma)
- Status
- RECRUITING
- Phase
- PHASE2
Elranatamab Expanded Access Protocol in Adults With Relapsed/Refractory Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Head-to-head Comparative Study of 18F-PSMA-1007 PET/CT and 18F-FDG PET/CT Imaging in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- NA
Assessing the Impact of a Financial Navigation Program for Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA